Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer

por Liu, Guang-Ming, Xu, Zi-Qiang, Ma, Hong-Shun
Publicado 2018

Increased IL-1α expression is correlated with bladder cancer malignant progression

por Yao, Shi-Jie, Ma, Hong-Shun, Liu, Guang-Ming, Gao, Yue, Wang, Wei
Publicado 2020

Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study

por He, Le-Ye, Zhang, Ming, Chen, Zhi-Wen, Yuan, Jian-Lin, Ye, Ding-Wei, Ma, Lu-Lin, Wei, Hui, Yang, Jiang-Gen, Chen, Shan, Wan, Ben, Xia, Shu-Jie, Weng, Zhi-Liang, Kong, Xiang-Bo, Wei, Qiang, Jin, Feng-Shuo, Zhang, Xiang-Hua, Qian, Wei-Qing, Wang, Shu-Sheng, Chen, Ying-He, Ma, Hong-Shun, Sun, Ying-Hao, Gao, Xu
Publicado 2018

Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)

por Jin, Ying-Hui, Zeng, Xian-Tao, Liu, Tong-Zu, Bai, Zhi-Ming, Dou, Zhong-Ling, Ding, De-Gang, Fan, Zhi-Lu, Han, Ping, Huang, Yi-Ran, Huang, Xing, Li, Ming, Li, Xiao-Dong, Li, Yi-Ning, Li, Xu-Hui, Liang, Chao-Zhao, Liu, Jiu-Min, Ma, Hong-Shun, Qi, Juan, Shi, Jia-Qi, Wang, Jian, Wang, De-Lin, Wang, Zhi-Ping, Wang, Yun-Yun, Wang, Yong-Bo, Wei, Qiang, Xia, Hai-Bo, Xing, Jin-Chun, Yan, Si-Yu, Zhang, Xue-Pei, Zheng, Guo-You, Xing, Nian-Zeng, He, Da-Lin, Wang, Xing-Huan
Publicado 2022